OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
2321$0.5457

Swang Chai Chuan Ltd

Food Retail & DistributionVerified

Swang Chai Chuan maintains a market price of MYR 0.54, translating to a market capitalization of MYR 540.08 million. The company trades at a price-to-earnings ratio of 16.25 and a price-to-book ratio of 1.97, both of which are above the industry median for Food Retail & Distribution firms. The enterprise value to EBITDA ratio is 14.25, and the enterprise value to revenue ratio is 0.68, indicating a relatively modest valuation multiple relative to revenue. The company's profitability metrics show a return on equity (ROE) of 12.14% and a return on assets (ROA) of 7.43%. These figures are in line with the industry's preferred metrics, which emphasize asset efficiency and capital returns. The gross profit margin is 12.95% (MYR 121.92 million on MYR 932.89 million revenue), and the operating margin is 4.74% (MYR 44.21 million on MYR 932.89 million revenue). These margins are consistent with the industry's median performance. Swang Chai Chuan's revenue is derived from a diversified portfolio of F&B and non-F&B products, including dairy, frozen food, packaged food, and personal care items. The company operates through multiple distribution channels, including hypermarkets, convenience stores, and F&B dealers. While the input data does not specify geographic revenue concentration, the company's operations are primarily based in Malaysia, with subsidiaries in Malaysia, suggesting a regional focus. The company's growth trajectory is modest, with no specific revenue growth rates provided in the input data. However, the company's operating income and net income have shown positive performance, with operating income at MYR 44.21 million and net income at MYR 33.24 million. The outlook for the current fiscal year is neutral, with no significant directional change expected in the near term. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio is 0.33, and the current ratio is 2.91, suggesting a relatively strong liquidity position. However, the company has a negative net cash position after subtracting total debt, which could pose a liquidity challenge if cash flow from operations is insufficient to service debt obligations. Recent events include the company's continued focus on expanding its distribution network and product portfolio. The company has not disclosed any major capital expenditures or strategic acquisitions in the latest financial filings. The company's risk factors include exposure to supply chain disruptions and competitive pressures in the retail and distribution sectors.

30-day price · 2321-0.02 (-3.9%)
Low$0.49High$0.56Close$0.49As of21 May, 00:00 UTC
Profile
CompanySwang Chai Chuan Ltd
Ticker2321.HK
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. Swang Chai Chuan Limited is an investment holding company engaged in the distribution and sales of food and beverages (F&B), as well as the provision of logistics and warehousing services.

Classification. Swang Chai Chuan is classified under the Consumer Non-Cyclicals economic sector, Food & Drug Retailing business sector, and Food Retail & Distribution industry with a confidence level of 0.92.

Swang Chai Chuan maintains a market price of MYR 0.54, translating to a market capitalization of MYR 540.08 million. The company trades at a price-to-earnings ratio of 16.25 and a price-to-book ratio of 1.97, both of which are above the industry median for Food Retail & Distribution firms. The enterprise value to EBITDA ratio is 14.25, and the enterprise value to revenue ratio is 0.68, indicating a relatively modest valuation multiple relative to revenue. The company's profitability metrics show a return on equity (ROE) of 12.14% and a return on assets (ROA) of 7.43%. These figures are in line with the industry's preferred metrics, which emphasize asset efficiency and capital returns. The gross profit margin is 12.95% (MYR 121.92 million on MYR 932.89 million revenue), and the operating margin is 4.74% (MYR 44.21 million on MYR 932.89 million revenue). These margins are consistent with the industry's median performance. Swang Chai Chuan's revenue is derived from a diversified portfolio of F&B and non-F&B products, including dairy, frozen food, packaged food, and personal care items. The company operates through multiple distribution channels, including hypermarkets, convenience stores, and F&B dealers. While the input data does not specify geographic revenue concentration, the company's operations are primarily based in Malaysia, with subsidiaries in Malaysia, suggesting a regional focus. The company's growth trajectory is modest, with no specific revenue growth rates provided in the input data. However, the company's operating income and net income have shown positive performance, with operating income at MYR 44.21 million and net income at MYR 33.24 million. The outlook for the current fiscal year is neutral, with no significant directional change expected in the near term. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio is 0.33, and the current ratio is 2.91, suggesting a relatively strong liquidity position. However, the company has a negative net cash position after subtracting total debt, which could pose a liquidity challenge if cash flow from operations is insufficient to service debt obligations. Recent events include the company's continued focus on expanding its distribution network and product portfolio. The company has not disclosed any major capital expenditures or strategic acquisitions in the latest financial filings. The company's risk factors include exposure to supply chain disruptions and competitive pressures in the retail and distribution sectors.
Key takeaways
  • Swang Chai Chuan trades at a price-to-earnings ratio of 16.25 and a price-to-book ratio of 1.97, indicating a moderate valuation.
  • The company's return on equity is 12.14%, and its return on assets is 7.43%, both in line with industry norms.
  • The company's revenue is derived from a diversified portfolio of F&B and non-F&B products, with a regional focus in Malaysia.
  • The company's liquidity position is moderate, with a current ratio of 2.91 and a debt-to-equity ratio of 0.33.
  • The company faces risks related to supply chain disruptions and competitive pressures in the retail and distribution sectors.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyMYR
Revenue$932.9M
Gross profit$121.9M
Operating income$44.2M
Net income$33.2M
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets$447.2M
Total liabilities$173.6M
Total equity$273.7M
Cash & equivalents
Long-term debt$89.7M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$0.54
Market cap$540.1M
Enterprise value$629.8M
P/E16.2
Reported non-GAAP P/E
EV/Revenue0.7
EV/Op income14.2
EV/OCF
P/B2.0
P/Tangible book2.0
Tangible book$273.7M
Net cash-$89.7M
Current ratio2.9
Debt/Equity0.3
ROA7.4%
ROE12.1%
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 234 companies
Metric2321Activity
Op margin4.7%2.8% medp25 0.9% · p75 5.9%above median
Net margin3.6%1.8% medp25 0.3% · p75 3.6%top quartile
Gross margin13.1%24.1% medp25 13.8% · p75 31.4%bottom quartile
CapEx / revenue-2.0% medp25 -3.8% · p75 -1.0%
Debt / equity33.0%56.0% medp25 14.0% · p75 113.8%below median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 05:31 UTC#1d8e73e9
Market quoteclose MYR 0.54 · shares 1.00B diluted
no public URL
2026-05-10 05:31 UTC#8b095603
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 05:34 UTCJob: 7ac807ae